Analysis of prognostic factors and efficacy of surgical treatment for non-small cell lung cancer: Department of surgery NTLDRI (1998-1999)

Pneumonologia i Alergologia Polska

Volumn 76, Issue 1, 2008, Pages 1-10

  Chabowski, Mariusz ^a,c   Orłowski, Tadeusz M ^a   Rabczenko, Daniel ^b  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^b NATIONAL INSTITUTE OF HYGIENE   (Poland)

^c Department of Surgery ^*  (Poland)

Author keywords

Non small cell lung cancer; Prognostic factors; Staging; Surgical treatment

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 40749108520     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ginsberg M.S. Epidemiology of lung cancer. Semin. Roentgenol. 2005; 40: 83-89.
2. Ortowski T., Rudziński P. Torakochirurgia 2004 - raport. Kardiochirurgia i Torakochirurgia Polska 2005; 2: 146-158.
3. Naruke T. Surgery in locally advanced non-small cell lung cancer. Lung Cancer 2003; 42: S11-S15.
4. Olak J., Colson Y. Gender differences in lung cancer: Have we really come a long way, baby? J. Thorac. Cardiovasc. Surg. 2004; 128: 346-351.
5. Wassawa-Kintu S., Gan W.Q., Man S.F., Pare P.D., Sin D.D. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005; 60: 570-575.
6. Kosacka M., Jankowska R. The epidemiology of lung cancer. Pneumonol. Alergol. Pol. 2007; 75: 76-80.
7. Bilfinger T. Surgical aspects in the treatment of lung cancer. Curr. Opin. Pulm. Med. 2004; 10: 261-265.
8. Dancey J., Le Chevalier T. Non-small cell lung cancer: an overview of current management. Eur. J. Cancer 1997; 33: S2-S7.
9. Ghosh S., Ahmed K., Hopkinson D.N., Vaughan R. Pulmonary adenocarcinoma is associated with poor long-term survival after surgical resection. Cancer 2004; 101: 2058-2066.
10. Hoffman P.C., Mauer A.M., Vokes E.E. Lung cancer. Lancet 2000; 355: 479-485.
11. Beadsmoore C.J., Screaton N.J. Classification, staging and prognosis of lung cancer. Eur. J. Radiol. 2003; 45: 8-17.
12. Alpard S.K., Zwischenberger B. Staging and surgery for non-small cell lung cancer (NSCLC). Surg. Oncol. 1999; 7: 25-43.
13. Ptaszek B., Chabowski M., Wiatr E. i wsp. Analysis of the treatment (neoadjuvant chemotherapy and surgery) in IIB and IIIA stages of non-small cell lung cancer. Pneumonol. Alergol. Pol. 2006; 74: 171-178.
14. Koyi H., Hillerdal G., Branden E. A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage and smoking habits. Lung Cancer 2002; 36: 9-14.
15. Goldstraw P., Crowley JJ. The International Association for the Study of Lung Cancer. International Staging Project on Lung Cancer. J. Thorac. Oncol. 2006; 1: 281-286.
16. Marciniak M., Kolodziej J., Pawelczyk K. The place of surgery in multimodal therapy of lung cancer. Adv. Clin. Exp. Med. 2004; 13: 1073-1077.
17. Watanabe S., Oda M., Go T. i wsp. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur. J. Cardiothorac. Surg. 2001; 20: 1007-1011.
18. Rostad H., Naalsund A., Strand T.E. i wsp. Results of pulmonary resection for lung cancer in Norway, patients older than 70 years. Eur. J. Cardiothorac. Surg. 2005; 27: 325-328.
19. Ikeda N., Hayashi A., Miura Y. i wsp. Present strategy of lung cancer screening and surgical management. Ann. Thorac. Cardiovasc. Surg. 2005; 11: 363-366.
20. Junker K. Prognostic factors in stage I/II non-small cell lung cancer. Lung Cancer 2001; 33 (supl. I): S17-S24.
21. Van Zandwijk N., Mooi W.J., Rodenhuis S. Prognostic factors in NSCLC. Recent experiences. Lung Cancer 1995; 12 (supl. I): S27-S33.
22. Van Rens M., Riviere A., Elbers H. i wsp. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000; 117: 374-379.
23. Goya T., Asamura H., Yoshimura H. i wsp. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005; 50: 227-234.
24. Damhuis R.A.M., Schutte P.R. Resection rates and postoperative mortality in 7899 patients with ling cancer. Lung Cancer 1996; 15: 151.
25. Wada H., Nakamura T., Nakamoto K., Maeda M., Watanabe Y. Thirty-day operative mortality for thoracotomy in lung cancer. J. Thorac. Cardiovasc. Surg. 1998; 115: 70-73.
26. Doddoli C., Aragon A., Barlesi F. i wsp. Does the extent of lymph node dissection influence outcome in patients with stage I non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 2005; 27: 680-685.
27. Roselli E.E., Murthy S.C., Rice T.W. i wsp. Atrial fibrillation complicating lung cancer resection. J. Thorac. Cardiovasc. Surg. 2005; 130: 438-444.
28. Radzikowska E., Głaz P., Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann. Oncol. 2002; 13: 1087-1093.
29. Wada H., Fukuse T., Hitomi S. Long-term survival of surgical cases of lung cancer. Lung Cancer 1995; 13: 269-274.
30. Berardi R., Brunelli A., Tamburrano T. i wsp. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Lung Cancer 2005; 49: 371-376.
31. Cangir A.K., Kutlaz H., Akal M., Gungor A., Oydemir N., Akaz H. Prognostic value of tumor size in non-small cell lung cancer larger than five centimeters in diameter. Lung Cancer 2004; 46: 325-331.
32. Lardinois D., Suter H., Hakki H., Rousson V., Betticher D., Ris H.B. Morbidity, survival and site of recurrence after mediastinal lymph node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann. Thorac. Surg. 2005; 80: 268-275.
33. Watanabe Y. TNM classification for lung cancer. Ann. Thorac. Cardiovasc. Surg. 2003; 9: 343-350.
34. Jassem J., Skokowski J., Dziadziuszko R. i wsp. Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. J. Thorac. Cardiovasc. Surg. 2000; 119: 1141-1146.
35. Ginsberg R.J. Surgical resection for non-small cell lung cancer: the impact of chemotherapy. Lung Cancer 1997; 18 (supl. 2): 79-80.
36. th edition. Lippincott Williams & Wilkins. Philadelphia, 2005.
37. Rzyman W., Dziadziuszko R., Skokowski J. i wsp. The influence of blood transfusion on survival in operated non-small cell lung cancer patients. J. Thorac. Cardiovasc. Surg. 2003; 126: 755-760.